Grace Therapeutics, Inc. (GRCE)
2.69
+0.12
(+4.67%)
USD |
NASDAQ |
Jun 01, 16:00
2.71
+0.02
(+0.74%)
After-Hours: 19:34
Grace Therapeutics EPS Diluted (Quarterly) : -0.1367 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Veru, Inc. | -0.1342 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.315M |
| Total Expenses (Quarterly) | 2.315M |
| Enterprise Value | 21.10M |
| Earnings Yield | -13.39% |
| Normalized Earnings Yield | -19.88 |